Halozyme Therapeutics
HALO
#1865
Rank
โ‚ฌ10.00 B
Marketcap
87,72ย โ‚ฌ
Share price
0.30%
Change (1 day)
44.09%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2026 (TTM): 3,06ย โ‚ฌ

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is 3,21ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 2,38ย โ‚ฌ a decrease over its 2024 EPS that were of 3,19ย โ‚ฌ.

EPS history for Halozyme Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)3,06ย โ‚ฌ28.76%
20252,38ย โ‚ฌ-25.43%
20243,19ย โ‚ฌ
20221,35ย โ‚ฌ-48.07%
20212,60ย โ‚ฌ196.87%
20200,87ย โ‚ฌ-292%
2019-0,46ย โ‚ฌ-9.09%
2018-0,50ย โ‚ฌ-237.5%
20170,36ย โ‚ฌ-149.38%
2016-0,74ย โ‚ฌ211.54%
2015-0,24ย โ‚ฌ-52.73%
2014-0,50ย โ‚ฌ-24.66%
2013-0,67ย โ‚ฌ48.98%
2012-0,45ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
6,09ย โ‚ฌ 89.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
0,65ย โ‚ฌ-79.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
28,15ย โ‚ฌ 777.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1,80ย โ‚ฌ-43.73%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-1,28ย โ‚ฌ-140.06%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-0,12ย โ‚ฌ-103.69%๐Ÿ‡บ๐Ÿ‡ธ USA